glutathione and tamoxfen The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells | BMC Cancer Tamoxifen Resistance in Breast Cancer
Tamoxifen Resistance in Breast Cancer PMC Enhanced mitochondrial metabolism: A new mechanism for driving Download Scientific Diagram PDF) Abstract 3902: Glutathione as a potential marker of tamoxifen resistance in breast cancer Tumor targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Nature Communications
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



